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Abstract
Amongst follicular lymphoma that transforms into a high-grade lymphoma, majority are diffuse large B cell
lymphoma. Here we reported a rare atypical Burkitt’s lymphoma transformation from an asymptomatic follicular
lymphoma. Lymph node biopsy showed a composite lymphoma with infiltration of the inter-follicular areas by
high grade small non-cleaved lymphoma cells amongst neoplastic follicles. Moreover, FISH and molecular genetic
study confirmed concomitant MYC translocations and t(14;18) in the high-grade component, thereby suggesting
the transformation of atypical Burkitt’s lymphoma from an undiagnosed antecedent follicular lymphoma. The
disease followed an aggressive clinical course, terminating in refractory disease 13 months after diagnosis. This is
followed by a comprehensive review of the literature on lymphoma transformations from underlying follicular
lymphoma after acquisition of MYC translocation, using Burkitt’s lymphoma, follicular lymphoma, transformation
and MYC translocations as keywords.
Follicular lymphoma (FL) is a low grade lymphoprolifera-
tive disease which frequently presents with generalized
lymphadenopathy and frequent bone marrow involvement.
The lymphoma arises from germinal centre lymphocytes
with three histological grades based on the number of cen-
troblasts in the neoplastic follicles. The pathogenesis of
disease is due to the overexpression of the anti-apoptotic
Bcl-2 associated with t(14;18), which juxtaposes BCL-2
gene on chromosome 18 to the enhancer of the immuno-
globulin heavy chain gene (IgH) locus on chromosome 14.
Moreover, as in their normal counterparts, the FL
cells have on-going somatic hypermutations [1], which
are implicated as a possible mechanism of high grade
transformation [2].
Up to 30% of patients with FL had high grade transfor-
mation of their disease [3]. In a study of 38 patients with
histological progression from antecedent follicular lym-
phoma, the most common histology was diffuse large
cell (68%), followed by diffuse mixed (21%), and small
non-cleaved cell histology only constituted 5% of transfor-
mations from FL [4]. On the other hand, in patients pre-
senting with atypical Burkitt’s lymphoma, about 25% were
transformations from an antecedent FL [5].
MYC, located at chromosome 8q24, is a transcription
factor involved in various translocations [t(8;14), t(8;22), t
(2;8)], leading to its dysregulation and hence carcinogen-
esis. Acquisition of MYC translocation was reported in
some high grade transformation of FL. Here we presented
a patient with atypical Burkitt’s lymphoma showing evi-
dence of transformation from an undiagnosed antecedent
F L .T h i si sf o l l o w e db yar e v i e wo ft h el i t e r a t u r eo n
lymphoma transformations from underlying FL after
acquisition of MYC translocation.
Report of a case
A 58 year-old man with good past health, presented with
progressive abdominal swelling for 4 months prior to
admission. He did not have any constitutional symptoms.
Physical examination showed a grossly distended abdomen
and a right submandibular lymph node measuring two
centimeter (cm). Computer tomography (CT) of the abdo-
men showed a huge contrast enhancing lobulated mass of
15.5 cm in diameter in the central abdomen (Figure 1A),
infiltrating the jejunum and ascending colon. In addition
to the soft tissue deposits on anterior abdominal wall,
multiple enlarged mesenteric lymph nodes and ascites
were noted. Biopsy of the submandibular lymph node
showed composite lymphoma with both grade 1 FL and
atypical Burkitt’s lymphoma. On the other hand, abdom-
inal lymph node biopsy showed diffuse infiltration by
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any medium, provided the original work is properly cited.atypical Burkitt’s lymphoma cells. Polymerase chain reac-
tion (PCR) for t(14;18) was positive while Epstein-Barr
virus encoded RNA (EBER) was negative in both the sub-
mandibular and abdominal lymph node specimens. The
serum lactate dehydrogenase (LDH) was 2732 U/L
(Normal < 401 U/L). The patient tested negative for
Human Immunodeficiency Virus (HIV) serology. Bone
marrow examination did not show lymphoma involve-
m e n t .H eh a db u l k yA n nA r b o rS t a g eI I I A atypical Bur-
kitt’s lymphoma transforming from underlying FL, and
Figure 1 (A) CT abdomen showed a huge enhancing lobulated mass of 15.5 cm in diameter in the central abdomen before
chemotherapy. (B) Reassessment CT abdomen after chemotherapy showed persistent central abdominal mass measured 7 cm in diameter.
Hwang et al. Diagnostic Pathology 2011, 6:63
http://www.diagnosticpathology.org/content/6/1/63
Page 2 of 7belonged to age-adjusted International Prognostic Index
high intermediate risk.
He received intravenous cyclophosphamide and vin-
cristine together with oral prednisolone. After initial
cytoreduction, he was induced with Stanford V regimen
[6]. He achieved only a partial response after a total of 5
cycles of Stanford regimen. Subsequent reassessment CT
scan showed that while the other small intra-abdominal
deposits reduced in size remarkably, there was only mod-
erate shrinkage of the major central abdominal mass,
which still measured seven cm in diameter (Figure 1B).
The chemotherapy was therefore switched to ifosfamide,
etoposide and high dose cytarabine (IVAC) [7]. The dis-
ease remained refractory despite two cycles of IVAC with
development of new hepatic lesions, progressive enlarge-
ment of central abdominal mass and serum LDH rising
to more than 5000 U/L. This was further complicated by
gastrointestinal bleeding but the bleeding source could
not be localized despite upper endoscopy and colono-
scopy. He was further salvaged with fludaradine, mitox-
antrone and dexamethasone but he succumbed finally to
refractory lymphoma.
Pathology
Excision biopsy of the submandibular lymph node
(Figure 2) showed composite histology with neoplastic
follicles, and a high grade interfollicular lymphoma-
tous infiltrate featuring starry sky pattern (Figure 2A
and 2B) with frequent mitotic and apoptotic bodies.
Immunohistochemical study showed that CD20 was
positive in the follicular, inter-follicular and diffuse
components whereas CD10 was strongly expressed by
the follicular component but was only weakly positive
in the interfollicular high grade component (Figure 2C
and 2D). The neoplastic follicles, but not the high-
grade interfollicular Burkitt’s lymphoma cells, showed
aberrant expression of BCL2 (Figure 2E). BCL6 was
expressed in both the neoplastic follicles and the aty-
pical Burkitt’s lymphoma cells. The interfollicular high
g r a d el y m p h o m ai n f i l t r a t es h o w e d>9 5 %M I B 1
immuno-reactivity (Figure 2F) while the neoplastic fol-
licles displayed MIB1 immuno-reactivity in 20%-30%
cells only. The histological features were consistent
with an atypical Burkitt’s lymphoma transforming
from grade 1 FL.
Ultrasound-guided biopsy of the abdominal mass
revealed only high grade lymphoma infiltration with
small round lymphoma cells carrying scanty cytoplasm,
irregular nuclear outline and prominent nucleoli. PCR
of DNA from both the submandibular lymph node and
the abdominal lymph node biopsy showed presence of t
(14;18). (Figure 3) FISH study on the high grade compo-
nent of the submandibular lymph node confirmed the
presence of MYC translocation (Figure 4).
Comment
Our patient had intermediate-high risk atypical Burkitt’s
lymphoma transforming from underlying FL. This is
based on the composite histology which showed the his-
tological and molecular features of FL (follicles with
aberrant expression of BCL2 protein and presence of
IgH-BCL2 translocation by PCR), and features of atypi-
cal Burkitt’s lymphoma in the interfollicular regions
(starry sky appearance, high mitotic rate, 95% MIB1
positivity, CD10 expression and FISH evidence of MYC
translocations in the small noncleaved lymphoma cells).
Despite the absence of a history of low grade lymphoma
in our patient, the evidence supporting transformation
from an underlying FL includes the followings. First, in
the submandibular lymph node, neoplastic follicles with
aberrant expression of BCL2 were present amongst the
high-grade lymphoma infiltration. Moreover, in the
abdominal lymph node biopsy, which contained atypical
Burkitt’s lymphoma cells only, t(14;18) translocation was
present, suggesting that the atypical Burkitt’s lymphoma
has transformed from an underlying FL which might
have been clinically occult prior to this presentation.
We believed the underlying FL cells acquired secondary
MYC translocations during their somatic hypermuta-
tions. It is highly likely that additional cytogenetic
abnormalities being acquired during this transformation
process contributing to the histological progression and
aggressive clinical course. We treated this patient with
the Stanford V regimen as first line therapy, which
yielded an unsatisfactory clinical response. Therefore we
switched to IVAC, which comprised of a combination of
different chemotherapeutic agents not seen by the
patient in previous chemotherapies. Unfortunately, the
disease was primarily refractory to chemotherapy.
Herein we reviewed the English literature of high-grade
lymphoma transformation from underlying FL upon
acquisition of MYC translocation as evidenced by meta-
phase cytogenetic, FISH or Southern hybridization.
Patients with either de novo high-grade lymphoma or
lymphoblastic leukemia, in which tumor cells possessed
concomitant t(14;18) and c-MYC translocations [8,9],
were not discussed as there was no evidence of underly-
ing FL by history or histology.
In a review of the patients with histological transforma-
tions from underlying FL acquiring MYC translocations,
two forms of presentation were identified. Majority
developed aggressive Burkitt’s transformation after a vari-
able period from the diagnosis of underlying FL, ranging
from 6 to 13 months [10-16]. Only three patients, in
addition to the present case, were reported in the litera-
ture presenting with concomitant Burkitt’sa n dF L .
(Table 1) These three patients had composite histology
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Figure 2 Histological features of the submandibular lymph node. The histology showed neoplastic follicles and a high grade interfollicular
lymphomatous infiltrate featuring starry sky pattern (Figure 2A, × 40 H&E; Figure 2B, × 200 H&E) with frequent mitotic and apoptotic bodies.
Immunohistochemical study showed that CD20 is strongly expressed in both the follicular and diffuse components (Figure 2C, H&E × 100), and
CD10 is strongly expressed in the follicular component while it is only weakly positive in the interfollicular high grade component (Figure 2D,
×100). The neoplastic follicles are positive for BCL2 (Figure 2E, × 100) and around 95% MIB1 immuno-reactivity is noted in the interfollicular high
grade lymphoma infiltrate (Figure 2F, × 100).
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specimen, as in our case [17-19].
The acquisition of MYC translocation is reported in
DLCL, lymphoblastic lymphoma and pre-B acute lym-
phoblastic leukemia transformation from FL, but only
rarely in atypical Burkitt’s lymphoma or Burkitt’s leuke-
mia transformation [4,5].
Unlike classical Burkitt’s lymphoma in which extranodal
presentation is most common, majority of these cases of
atypical Burkitt’s transformation had nodal presentation.
All patients had a uniformly aggressive disease with poor
survivals ranging from 4-13 months from the diagnosis of
Burkitts’ transformation. (Table 1) Moreover, the presence
of combined MYC dysregulation, and BCL2 upregulation
at diagnosis already predicted a very aggressive clinical
course with rapid transformation into a high-grade
lymphoma [4]. Furthermore, while MYC dysregulation
associated with t(8;14) generally involved a different IgH
allele from that involved by the underlying t(14;18), there
are reports of rare transformation involving a complex
Figure 3 PCR for t(14;18) showed positive amplifcation of the same size in both the submandibular and abdominal lymph node.
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MYC are translocated to the same IgH allele [9]. Irrespec-
tive of the temporal relation of the histological progression
and cytogenetic alterations, all the reported cases
including our present case are very aggressive and highly
resistant to chemotherapy. T h e r ei ss o m ee v i d e n c et h a t
radiotherapy may play an important role in disease control
in this group of patients [20].
Figure 4 FISH analysis of the high grade component of the submandibular lymph node biopsy specimen showed the presence of one
fused signal (yellow arrows) and two split signal (white arrows) in single cell, indicating the presence of translocation of MYC.
Table 1 Patients with composite histology of atypical Burkitt’s and follicular lymphoma
Patient This case 1 2 3
Age 58 77 52 44
Sex M M F M
Site and stage at
initial presentation
Submand LN + abd LN,
ascites
Stage III
Generalized
LN + BM
Stage IV
LN
Stage III
LN + BM
Stage IV
Temporal sequence of
transformation
Concomitant Concomitant Concomitant Concomitant
Histology Composite
Lymphoma
Composite follicular + Burkitt’s Composite Follicular + Burkitt’s Composite
Lymphoma
Cytogenetics at
transformation
t(14;18) by PCR +
MYC translocation by
FISH
t(14;18) + t(8;14) t(14;18) in follicular area
t(14;18) + t(8;14) in transformed area
t(14;18) + t(8;14)
Treatment Chemo Chemo Chemo ® CR Chemo ® CR
Outcome Primary refractory died 13
months after Dx
Primary refractory and died 4
months after diagnosis
Relapsed 3 months later with partial
response to salvage chemo
CNS relapse 6 months
later and died
Reference 17 18 19
Abbreviations: F: female; M: male; LN: lymph node; FISH: fluorescent in-situ hybridization; NA: not available; BM: bone marrow;CNS central nervous system;
Dx: diagnosis; CR: complete remission; PR: partial remission; NR: non-remission;
Hwang et al. Diagnostic Pathology 2011, 6:63
http://www.diagnosticpathology.org/content/6/1/63
Page 6 of 7In summary, atypical Burkitt’s transformation in our
patient was illustrated by the composite histology, and
FISH evidence of MYC translocation in addition to the
presence of t(14;18). Moreover, additional MYC translo-
cations in underlying FL may lead to high-grade lym-
phoma transformations with a wide range of histological
subtypes in addition to atypical Burkitt’sl y m p h o m a /
leukemia.
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